Adriana Moreno Rodriguez Adriana Moreno Rodríguez

Dr. Adriana Moreno Rodriguez Adriana Moreno Rodríguez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JFJosé A. De Fuentes-Vicente
José A. De Fuentes-Vicente
NSNancy G. Santos-Hernández
Nancy G. Santos-Hernández
CRChristian Ruiz-Castillejos
Christian Ruiz-Castillejos
EEEduardo E. Espinoza-Medinilla
Eduardo E. Espinoza-Medinilla
AFA. Laura Flores-Villegas
A. Laura Flores-Villegas
DVDolores G. Vidal
Dolores G. Vidal
Chagas disease is one of the most important tropical infections in the world and mainly affects poor people. The causative agent is the hemoflagellate protozoan Trypanosoma cruzi, which circulates among insect vectors and mammals throughout the Americas. A large body of research on Chagas disease has shown the complexity of this zoonosis, and controlling it remains a challenge for public health systems. Although knowledge of Chagas disease has advanced greatly, there are still many gaps, and it is necessary to continue generating basic and applied research to create more effective control strategies. The aim of this review is to provide up-to-date information on the components of Chagas disease and highlight current trends in research. We hope that this review will be a starting point for beginners and facilitate the search for more specific information.

24 June 2021 in JMIR Serious Games
Verified
Journal Article
Open access
MBMaría del Pilar Beristain-Colorado María del Pilar Beristain-Colorado
María del Pilar Beristain-Colorado María del Pilar Beristain-Colorado
JAJorge Fernando Ambros-Antemate
Jorge Fernando Ambros-Antemate
Marciano Vargas TreviñoMarciano Vargas Treviño
Marciano Vargas Treviño
JGJaime Gutiérrez Gutiérrez
Jaime Gutiérrez Gutiérrez
ARAdriana Moreno Rodriguez Adriana Moreno Rodríguez
Adriana Moreno Rodriguez Adriana Moreno Rodríguez
RTRafael Torres-Rosas
Rafael Torres-Rosas
Background: Serious games have been used as supportive therapy for traditional rehabilitation. However, most are designed without a systematic process to guide their development from the phases of requirement identification, planning, design, construction, and evaluation, which reflect the lack of adaptation of rehabilitation requirements and thus the patient’s needs.Objective: The aim of this study was to propose a conceptual framework with standardized elements for the development of information systems by using a flexible and an adaptable process centered on the patient’s needs and focused on the creation of serious games for physical rehabilitation.Methods: The conceptual framework is based on 3 fundamental concepts: (1) user-centered design, which is an iterative design process focused on users and their needs at each phase of the process, (2) generic structural activities of software engineering, which guides the independent development process regardless of the complexity or size of the problem, and (3) gamification elements, which allow the transformation of obstacles into positive and fun reinforcements, thereby encouraging patients in their rehabilitation process.Results: We propose a conceptual framework to guide the development of serious games through a systematic process by using an iterative and incremental process applying the phases of context identification, user requirements, planning, design, construction of the interaction devices and video game, and evaluation.Conclusions: This proposed framework will provide developers of serious games a systematic process with standardized elements for the development of flexible and adaptable software with a high level of patient commitment, which will effectively contribute to their rehabilitation process.

Verified
Journal Article
Open access
PDF file
Melissa F. AdasmeMelissa F. Adasme
Melissa F. Adasme
SBSarah Naomi Bolz
Sarah Naomi Bolz
LALauren Adelmann
Lauren Adelmann
SSSebastian Salentin
Sebastian Salentin
VHV. Joachim Haupt
V. Joachim Haupt
MSMichael Schroeder
Michael Schroeder
Chagas disease, caused by the parasite Trypanosoma cruzi, affects millions of people in South America. The current treatments are limited, have severe side effects, and are only partially effective. Drug repositioning, defined as finding new indications for already approved drugs, has the potential to provide new therapeutic options for Chagas. In this work, we conducted a structure-based drug repositioning approach with over 130,000 3D protein structures to identify drugs that bind therapeutic Chagas targets and thus represent potential new Chagas treatments. The screening yielded over 500 molecules as hits, out of which 38 drugs were prioritized following a rigorous filtering process. About half of the latter were already known to have trypanocidal activity, while the others are novel to Chagas disease. Three of the new drug candidates—ciprofloxacin, naproxen, and folic acid—showed a growth inhibitory activity in the micromolar range when tested ex vivo on T. cruzi trypomastigotes, validating the prediction. We show that our drug repositioning approach is able to pinpoint relevant drug candidates at a fraction of the time and cost of a conventional screening. Furthermore, our results demonstrate the power and potential of structure-based drug repositioning in the context of neglected tropical diseases where the pharmaceutical industry has little financial interest in the development of new drugs.

10 November 2023 in JMIR Formative Research
Verified
Journal Article
Open access
JAJorge Fernando Ambros-Antemate
Jorge Fernando Ambros-Antemate
MBMaría del Pilar Beristain-Colorado María del Pilar Beristain-Colorado
María del Pilar Beristain-Colorado María del Pilar Beristain-Colorado
Marciano Vargas TreviñoMarciano Vargas Treviño
Marciano Vargas Treviño
JGJaime Gutiérrez Gutiérrez
Jaime Gutiérrez Gutiérrez
PHPedro Antonio Hernández-Cruz
Pedro Antonio Hernández-Cruz
ARAdriana Moreno Rodriguez Adriana Moreno Rodríguez
Adriana Moreno Rodriguez Adriana Moreno Rodríguez
Background: Insufficient levels of treatment adherence can have adverse effects on the outcomes of physical rehabilitation. To address this issue, alternative approaches to traditional therapies, such as serious games, have been designed to enhance adherence. Nevertheless, there remain gaps in the development of serious games concerning the effective implementation of motivation, engagement, and the enhancement of treatment adherence. Objective: This study aims to design a conceptual framework for the development of serious games that incorporate essential adherence factors to enhance patient compliance with physical rehabilitation programs. Methods: We formulated a conceptual framework using iterative techniques inspired by a conceptual framework analysis. Initially, we conducted a comprehensive literature review, concentrating on the critical adherence factors in physical rehabilitation. Subsequently, we identified, categorized, integrated, and synthesized the concepts derived from the literature review to construct the conceptual framework. Results: The framework resembles a road map, comprising 3 distinct phases. In the initial phase, the patient’s characteristics are identified through an initial exploration. The second phase involves the development of a serious game, with a focus on enhancing treatment adherence by integrating the key adherence factors identified. The third phase revolves around the evaluation of the serious game. These phases are underpinned by 2 overarching themes, namely, a user-centered design and the GameFlow model. Conclusions: The conceptual framework offers a detailed, step-by-step guide for creating serious games that incorporate essential adherence factors, thereby contributing to improved adherence in the physical rehabilitation process. To establish its validity, further evaluations of this framework across various physical rehabilitation programs and user groups are necessary.

11 November 2021 in JMIR Serious Games
Verified
Journal Article
Open access
JAJorge Fernando Ambros-Antemate
Jorge Fernando Ambros-Antemate
MBMaría del Pilar Beristain-Colorado María del Pilar Beristain-Colorado
María del Pilar Beristain-Colorado María del Pilar Beristain-Colorado
Marciano Vargas TreviñoMarciano Vargas Treviño
Marciano Vargas Treviño
JGJaime Gutiérrez Gutiérrez
Jaime Gutiérrez Gutiérrez
PHPedro Antonio Hernández-Cruz
Pedro Antonio Hernández-Cruz
ARAdriana Moreno Rodriguez Adriana Moreno Rodríguez
Adriana Moreno Rodriguez Adriana Moreno Rodríguez
Background: Serious games are a support in the rehabilitation process for treating people with physical disabilities. However, many of these serious games are not adapted to the patient’s needs because they are not developed with a software engineering framework with a set of activities, actions, and tasks that must be executed when creating a software product. Better serious games for rehabilitation will be developed if the patient and therapist requirements are identified, the development is planned, and system improvements and feedback are involved. The goal is that the serious game must offer a more attractive environment, while maintaining patient interest in the rehabilitation process. Objective: This paper submits the results of a systematic review of serious games in physical rehabilitation identifying the benefits of using a software engineering framework. Methods: A systematic research was conducted using PubMed, PEDro (Physiotherapy Evidence Database), IEEE Xplore, ScienceDirect, ACM Digital Library, Mary Ann Liebert, Taylor & Francis Online, Wiley Online Library, and Springer databases. The initial search resulted in 701 papers. After assessing the results according to the inclusion criteria, 83 papers were selected for this study. Results: From the 83 papers reviewed, 8 used a software engineering framework for its development. Most of them focused their efforts on 1 or more aspects, such as data acquisition and processing, game levels, motivation, therapist supervision. Conclusions: This systematic review proves that most of the serious games do not use a software engineering framework for their development. As a result, development systems overlook several aspects and do not have a standardized process, eventually omitting important implementation aspects, which impact the patient’s recovery time.

29 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Luis Donaldo Gonzalez MoralesLuis Donaldo Gonzalez Morales
Luis Donaldo Gonzalez Morales
ARAdriana Moreno Rodriguez Adriana Moreno Rodríguez
Adriana Moreno Rodriguez Adriana Moreno Rodríguez
LVLenci K. Vázquez-Jiménez
Lenci K. Vázquez-Jiménez
Timoteo Delgado MaldonadoTimoteo Delgado Maldonado
Timoteo Delgado Maldonado
Alfredo Juárez-SaldivarAlfredo Juárez-Saldivar
Alfredo Juárez-Saldivar
Gildardo RiveraGildardo Rivera
Gildardo Rivera
Cutaneous leishmaniasis (CL) is a public health problem affecting more than 98 countries worldwide. No vaccine is available to prevent the disease, and available medical treatments cause serious side effects. Additionally, treatment failure and parasite resistance have made the development of new drugs against CL necessary. In this work, a virtual screening of natural products from the BIOFACQUIM and Selleckchem databases was performed using the method of molecular docking at the triosephosphate isomerase (TIM) enzyme interface of Leishmania mexicana (L. mexicana). Finally, the in vitro leishmanicidal activity of selected compounds against two strains of L. mexicana, their cytotoxicity, and selectivity index were determined. The top ten compounds were obtained based on the docking results. Four were selected for further in silico analysis. The ADME-Tox analysis of the selected compounds predicted favorable physicochemical and toxicological properties. Among these four compounds, S-8 (IC50 = 55 µM) demonstrated a two-fold higher activity against the promastigote of both L. mexicana strains than the reference drug glucantime (IC50 = 133 µM). This finding encourages the screening of natural products as new anti-leishmania agents.